Illuminating biological pathways for drug targeting in head and neck squamous cell carcinoma

Head and neck squamous cell carcinoma (HNSCC) remains a morbid disease with poor prognosis and treatment that typically leaves patients with permanent damage to critical functions such as eating and talking. Currently only three targeted therapies are FDA approved for use in HNSCC, two of which are...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Choonoo, Gabrielle, Blucher, Aurora S., Higgins, Samuel, Boardman, Mitzi, Jeng, Sophia, Zheng, Christina, Jacobs, James, Anderson, Ashley, Chamberlin, Steven, Evans, Nathaniel, Vigoda, Myles, Cordier, Benjamin, Tyner, Jeffrey W., Kulesz-Martin, Molly, McWeeney, Shannon K., Laderas, Ted
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6785123/
https://ncbi.nlm.nih.gov/pubmed/31596908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0223639
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados